We are live on ! Find out more
TTRX

Turn Therapeutics
TTRX

20 hedge funds and large institutions have $1.48M invested in Turn Therapeutics in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.01% less ownership

Funds ownership: 1.58% → 1.57% (-0.01%)

9% less funds holding

Funds holding: 22 → 20 (-2)

20% less capital invested

Capital invested by funds: $1.84M → $1.48M (-$358K)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DI
DDFG Inc
California
+$71.1K
2
TS
Tamar Securities
California
+$58.5K
3
UBS Group
UBS Group
Switzerland
+$1.56K
4
LPL Financial
LPL Financial
California
+$1.17K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$101K
2
Citadel Advisors
Citadel Advisors
Florida
-$82.7K
3
Jane Street
Jane Street
New York
-$67.6K
4
XT
XTX Topco
Cayman Islands
-$21.2K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
DI
1
DDFG Inc
California
$226K +$71.1K +18,246 +35%
Millennium Management
2
Millennium Management
New York
$223K -$101K -25,866 -27%
WSC
3
Wellington Shields & Co
New York
$210K – – –
VCM
4
Vanguard Capital Management
Pennsylvania
$158K +$193K +49,450 New
TS
5
Tamar Securities
California
$96K +$58.5K +15,000 +100%
BBHC
6
Brown Brothers Harriman & Co
New York
$75.8K – – –
XT
7
XTX Topco
Cayman Islands
$63.1K -$21.2K -5,446 -22%
HighTower Advisors
8
HighTower Advisors
Illinois
$63K – – –
RW
9
RVW Wealth
California
$57.6K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$54.9K – – –
MMA
11
Miracle Mile Advisors
California
$51.2K – – –
Bank of America
12
Bank of America
North Carolina
$45.2K – – –
LPL Financial
13
LPL Financial
California
$42.6K +$1.17K +300 +2%
VFT
14
Vanguard Fiduciary Trust
Pennsylvania
$39.9K +$48.6K +12,480 New
HCM
15
Hodges Capital Management
Texas
$32K – – –
Morgan Stanley
16
Morgan Stanley
New York
$32K – – –
BTI
17
Blue Trust Inc
Georgia
$3.59K – – –
Wells Fargo
18
Wells Fargo
California
$3.2K – – –
UBS Group
19
UBS Group
Switzerland
$1.28K +$1.56K +400 New
PK
20
Pflug Koory
Nebraska
$544 – – –
Citadel Advisors
21
Citadel Advisors
Florida
– -$82.7K -20,986 Closed
Jane Street
22
Jane Street
New York
– -$67.6K -17,169 Closed
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
– -$1K -267 Closed
TRCT
24
Tower Research Capital (TRC)
New York
– -$540 -137 Closed

TTRX Hedge Fund Activity: Q1 2026 in Review

20 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Turn Therapeutics (TTRX) for Q1 2026, worth a combined $1.48M — down 20% from $1.84M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TTRX and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was DDFG Inc, adding an estimated $71.1K. The largest seller was Millennium Management, cutting an estimated $101K.

  • 20 institutional investors held Turn Therapeutics (TTRX) as of Q1 2026, down from 22 in Q4 2025.
  • Funds reported $1.48M of Turn Therapeutics stock for Q1 2026, down 20% quarter-over-quarter.
  • 3 funds opened new Turn Therapeutics positions in Q1 2026 and 4 closed out, a net change of -1 holder.
  • The largest Turn Therapeutics buyer in Q1 2026 was DDFG Inc, an estimated $71.1K added.
  • The largest Turn Therapeutics seller in Q1 2026 was Millennium Management, an estimated $101K sold.

Based on aggregated 13F filings for Q1 2026.